Epigenomics Ag Stock Probability of Future Pink Sheet Price Finishing Over 1.06

EPGNF Stock  USD 0.50  0.00  0.00%   
Epigenomics' future price is the expected price of Epigenomics instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Epigenomics AG performance during a given time horizon utilizing its historical volatility. Check out Epigenomics Backtesting, Epigenomics Valuation, Epigenomics Correlation, Epigenomics Hype Analysis, Epigenomics Volatility, Epigenomics History as well as Epigenomics Performance.
  
Please specify Epigenomics' target price for which you would like Epigenomics odds to be computed.

Epigenomics Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Epigenomics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Epigenomics AG can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Epigenomics AG is way too risky over 90 days horizon
Epigenomics AG has some characteristics of a very speculative penny stock
Epigenomics AG appears to be risky and price may revert if volatility continues
The company reported the revenue of 6.2 M. Net Loss for the year was (2.43 M) with profit before overhead, payroll, taxes, and interest of 6.07 M.
Epigenomics AG has accumulated about 15.77 M in cash with (4.15 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.96, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 35.0% of the company shares are held by company insiders

Epigenomics Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Epigenomics Pink Sheet often depends not only on the future outlook of the current and potential Epigenomics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Epigenomics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding15.5 M

Epigenomics Technical Analysis

Epigenomics' future price can be derived by breaking down and analyzing its technical indicators over time. Epigenomics Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Epigenomics AG. In general, you should focus on analyzing Epigenomics Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.

Epigenomics Predictive Forecast Models

Epigenomics' time-series forecasting models is one of many Epigenomics' pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Epigenomics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.

Things to note about Epigenomics AG

Checking the ongoing alerts about Epigenomics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Epigenomics AG help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Epigenomics AG is way too risky over 90 days horizon
Epigenomics AG has some characteristics of a very speculative penny stock
Epigenomics AG appears to be risky and price may revert if volatility continues
The company reported the revenue of 6.2 M. Net Loss for the year was (2.43 M) with profit before overhead, payroll, taxes, and interest of 6.07 M.
Epigenomics AG has accumulated about 15.77 M in cash with (4.15 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.96, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 35.0% of the company shares are held by company insiders
Check out Epigenomics Backtesting, Epigenomics Valuation, Epigenomics Correlation, Epigenomics Hype Analysis, Epigenomics Volatility, Epigenomics History as well as Epigenomics Performance.
You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Complementary Tools for Epigenomics Pink Sheet analysis

When running Epigenomics' price analysis, check to measure Epigenomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Epigenomics is operating at the current time. Most of Epigenomics' value examination focuses on studying past and present price action to predict the probability of Epigenomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Epigenomics' price. Additionally, you may evaluate how the addition of Epigenomics to your portfolios can decrease your overall portfolio volatility.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Please note, there is a significant difference between Epigenomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Epigenomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Epigenomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.